Results 261 to 270 of about 499,895 (395)

Transcatheter Aortic Valve Replacement for a Severe Aortic Valve Stenosis Coexisting with Hypertrophic Obstructive Cardiomyopathy - A Tale of Two Obstructions. [PDF]

Acta Cardiol Sin
Lin YS, Yu CL, Lee WL, Lin WW, Liang KW.
europepmc   +1 more source

Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

European Journal of Heart Failure, EarlyView.
Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.
Melanie Paillard, Mahmoud Abdellatif, Ioanna Andreadou, Christian Bär, Luc Bertrand, Bianca J.J.M. Brundel, Gemma Chiva‐Blanch, Sean M. Davidson, Dana Dawson, Fabio Di Lisa, Paul Evans, Zoltan Giricz, Derek J. Hausenloy, Petra Kleinbongard, Frank Lezoualc'h, Elisa Liehn, Christoph Maack, Ange Maguy, Elizabeth Murphy, Cinzia Perrino, Maurizio Pesce, Peter P. Rainer, Katrin Streckfuss‐Bömeke, Matthias Thielmann, Rong Tian, Carlo G. Tocchetti, Jolanda Van Der Velden, Sophie Van Linthout, Serena Zacchigna, Thomas Krieg   +29 more
wiley   +1 more source

Stressed out with Sepsis. [PDF]

, 2019
Baram, Michael, Hilton, Robert
core   +1 more source

Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? [PDF]

, 2003
Steve R. Ommen
openalex   +1 more source

Hypertrophic Obstructive Cardiomyopathy

Journal of Interventional Cardiology, 1996
openaire   +2 more sources

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura, Mingming Yang, Alasdair D. Henderson, Pardeep S. Jhund, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, Gerasimos Filippatos, Grzegorz Gajos, Katharina Mueller, Andrea Glasauer, Katja Rohwedder, Prabhakar Viswanathan, Carolyn S.P. Lam, Naoki Sato, Michele Senni, Adriaan A. Voors, Faiez Zannad, Mehmet B. Yilmaz, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray, on behalf of the FINEARTS‐HF Committees and Investigators   +23 more
wiley   +1 more source

Patient With an Anomalous Left Coronary Artery and Hypertrophic Obstructive Cardiomyopathy. [PDF]

JACC Case Rep
O'Gorman KJ, Moulton MN, Gustafson JD, Cahill MS, Gore RS.   +4 more
europepmc   +1 more source

Genotype‐guided cardiac device intervention in LMNA‐related cardiac conduction disorder: The need for timely genetic testing

European Journal of Heart Failure, EarlyView.
Sudden cardiac death is a catastrophic event, making its prevention important. However, patient selection for primary prevention remains controversial. We report two cases of cardiac conduction disorder initially treated with permanent pacemaker implantation.
Shunsuke Inoue, Zhehao Dai, Tsukasa Oshima, Seitaro Nomura, Takashi Hiruma, Ryo Abe, Kanna Fujita, Manami Katoh, Toshiyuki Ko, Yu Shimizu, Masamichi Ito, Kenichiro Yamagata, Junichi Ishida, Eisuke Amiya, Masaru Hatano, Norifumi Takeda, Hiroyuki Morita, Katsuhito Fujiu, Norihiko Takeda, Issei Komuro   +19 more
wiley   +1 more source

Left ventricle myocardial remodeling following septal myectomy in patients with hypertrophic obstructive cardiomyopathy. [PDF]

J Cardiovasc Magn Reson
Lu G, Cao L, Ou J, Luo X, Zhu W, Du Z, Liu J, Yang Y, Zhang X, Wei P, Wu H, Guo H, Liu H.   +12 more
europepmc   +1 more source

Implantable cardioverter‐defibrillators in ischaemic versus non‐ischaemic heart failure: Insights from the VICTORIA trial

European Journal of Heart Failure, EarlyView.
Mode of death stratified by implantable cardioverter‐defibrillator (ICD) status. CI, confidence interval; CV, cardiovascular; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; SCD, sudden cardiac death. Abstract Aims Guidelines recommend the use of implantable cardioverter‐defibrillators (ICDs) to reduce the risk
Pishoy Gouda, Wendimagegn Alemayehu, Adriaan A. Voors, Carolyn S.P. Lam, Justin Ezekowitz, Burkert Pieske, Javed Butler, Cynthia M. Westerhout, Haran Yogasundaram, Roopinder K. Sandhu, Paul W. Armstrong, on behalf of the VICTORIA Study Group   +11 more
wiley   +1 more source